The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Latent TB Infection Treatment
- Treatment Regimens for Latent TB Infection (LTBI): This CDC website compares different LTBI treatment regimens
- Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
- Updated Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
- NTCA Provider Guidance: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI): This two-page PDF is designed for providers to learn more about the 3HP regimen for treating LTBI. Note that NTCA is collecting minimal contact information prior to download, which will be used for evaluation purposes to learn how this resource is being used and by whom.
- Recommendations for Monitoring Treatment of LTBI Using Isoniazid & Rifapentine: currently being updated